Growth factors initially mediate their effects on target cells by binding to specific surface membrane receptors. The mechanism(s) involved in triggering and sustaining transmembrane signals generated by this interaction is central to the issue of regulation of cell growth and differentiation and in regulation of membrane receptor expression in general. The nature of this ligand-receptor interaction for Interleukain-3 (IL-3), a requisite multipotential regulator of bone marrow cell growth, can now be studied effectively in detail because of the availability of purified IL-3 receptor and the mechanism of ligand-receptor transmembrane signalling. Quantitative isolation of IL-3 receptor for monoclonal antibody production, limited amino acid sequencing and gene cloning will be carried out. Once the gene for the IL-3 receptor at various stages of cell growth and differentiation and determine whether the IL-3 receptor gene may be differentially expressed or even altered in cell types whose growth is independent of IL-3, i.e. as a result of retroviral transformation. By analyzing the IL-3 receptor gene and its product, I plan to better understand its method of regulation, to begin to dissect the functional organization of the molecule, and to examine the biochemical role of the IL- 3 receptor in normal progenitor cell growth and differentiation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA044649-03
Application #
3187344
Study Section
Cellular Biology and Physiology Subcommittee 1 (CBY)
Project Start
1987-05-01
Project End
1990-04-30
Budget Start
1989-05-01
Budget End
1990-04-30
Support Year
3
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Yang, Mingli; Wu, Song; Jia, Jinghua et al. (2011) JAZ mediates G1 cell cycle arrest by interacting with and inhibiting E2F1. Cell Cycle 10:2390-9
May, William Stratford; Hoare, Kishalay; Hoare, Sarasija et al. (2010) Tnk1/Kos1: a novel tumor suppressor. Trans Am Clin Climatol Assoc 121:281-92; discussion 292-3
Deng, Xingming; Gao, Fengqin; May, W Stratford (2009) Protein phosphatase 2A inactivates Bcl2's antiapoptotic function by dephosphorylation and up-regulation of Bcl2-p53 binding. Blood 113:422-8
Hoare, Sarasija; Hoare, Kishalay; Reinhard, Mary K et al. (2009) Functional characterization of the murine Tnk1 promoter. Gene 444:1-9
Cao, Xuefang; Bennett, Richard L; May, W Stratford (2008) c-Myc and caspase-2 are involved in activating Bax during cytotoxic drug-induced apoptosis. J Biol Chem 283:14490-6
Wang, Yan-Yi; Deng, Xingming; Xu, Lijun et al. (2008) Bcl2 enhances induced hematopoietic differentiation of murine embryonic stem cells. Exp Hematol 36:128-39
Yang, Mingli; Wu, Song; Su, Xuekun et al. (2006) JAZ mediates G1 cell-cycle arrest and apoptosis by positively regulating p53 transcriptional activity. Blood 108:4136-45
Deng, Xingming; Gao, Fengqin; Flagg, Tammy et al. (2006) Bcl2's flexible loop domain regulates p53 binding and survival. Mol Cell Biol 26:4421-34
Deng, Xingming; Gao, Fengqin; Flagg, Tammy et al. (2004) Mono- and multisite phosphorylation enhances Bcl2's antiapoptotic function and inhibition of cell cycle entry functions. Proc Natl Acad Sci U S A 101:153-8
Hoare, Kishalay; Hoare, Sarasija; Smith, Orla M et al. (2003) Kos1, a nonreceptor tyrosine kinase that suppresses Ras signaling. Oncogene 22:3562-77

Showing the most recent 10 out of 40 publications